Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. · Phase II
704 (USA) · Dr. Tanaka
consented 2014-04-23
AEs
2
Serious
0
Dropout signal
–
Adverse events
mild
assessed
Mild PRURITUS — outcome: NOT RECOVERED/NOT RESOLVED; onset 2014-07-04 (study day 73.0); relationship: PROBABLE
mild
assessed
Mild RASH — outcome: NOT RECOVERED/NOT RESOLVED; onset 2014-05-23 (study day 31.0); relationship: PROBABLE
Data queries
No data queries.